October 28, 2025 | Pharmaceutical Technology
Found Health has become the latest telehealth company to offer a microdosing program with weight loss jabs, despite an absence of peer-reviewed scientific evidence that shows microdosing GLP-1RA drugs is effective or safe. AACE President Scott D. Isaacs, MD, FACP, FACE, emphasized that AACE does not support the routine use of microdosing GLP-1RA medications in clinical care and recommends adherence to FDA-approved dosing guidelines for these agents. Learn more in the full article on Pharmaceutical Technology.
https://www.pharmaceutical-technology.com/news/glp-1ra-microdosing-trend-continues-despite-anecdotal-evidence/?cf-view